title: White matter disease: optimizing rituximab therapy for neuromyelitis optica.
authors: Dean M
authors: DM
authors: Wingerchuk
authors: Brian G
authors: BG
authors: Weinshenker
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D006801:Humans; D056784:Leukoencephalopathies / Q000188:drug therapy* / Q000276:immunology; D009471:Neuromyelitis Optica / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab